Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R
ClinicalTrials.gov study NCT00534469. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Bcl-2 Inhibitors Combined With Azacytidine and Chemotherapy in Elderly Patients With Previously Untreated AML
ClinicalTrials.gov study NCT05053425. IPD Sharing: NO. Countries: 1. Publications: 0.
A Randomized Placebo-controlled Phase 2 Study of Decitabine With or Without Eltrombopag in AML Patients
ClinicalTrials.gov study NCT02446145. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Azacytidine Plus FLAG for Relapsed or Refractory AML
ClinicalTrials.gov study NCT02275663. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of DSP-5336 in Relapsed/Refractory AML/ ALL With or Without MLL Rearrangement or NPM1 Mutation
ClinicalTrials.gov study NCT04988555. IPD Sharing: UNDECIDED. Countries: 11. Publications: 0.
TEAM-Trial: Targeting Epigenetic Therapy Resistance in AML With Bortezomib
ClinicalTrials.gov study NCT04173585. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Eltrombopag Used in Thrombocytopenia After Comsolidation Therapy in AML
ClinicalTrials.gov study NCT03701217. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
LAM07: Study to Analyze the Efficacy of a Risk Adapted Treatment Strategy, Including Gemtuzumab Ozogamicin (GO) During Consolidation, for Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01041040. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bortezomib Combined With DAG Regimen in the Treatment of Refractory/Relapsed AML
ClinicalTrials.gov study NCT05982756. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ex-vivo Expanded γδ T-lymphocytes (OmnImmune®) in Patients With Acute Myeloid Leukaemia (AML)
ClinicalTrials.gov study NCT03790072. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Alvocidib in Combination With Decitabine and Venetoclax in Patients With Relapsed or Refractory AML or as Frontline Therapy in Unfit Patients With AML
ClinicalTrials.gov study NCT04493099. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ACHIEVE - Efficacy and Effectiveness of Adoptive Cellular tHerapy wIth Ex-Vivo Expanded Allogeneic γδ T-lymphocytes (TCB008) for Patients With Refractory or Relapsed Acute Myeloid Leukaemia (AML)
ClinicalTrials.gov study NCT05358808. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL
ClinicalTrials.gov study NCT05153330. IPD Sharing: NO. Countries: 5. Publications: 0.
Safety and Clinical Activity Study of Combination Azacitidine and Avelumab in Patients With Acute Myeloid Leukemia (AML) and Minimal Residual Disease (MRD)
ClinicalTrials.gov study NCT03699384. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Using Multiparametric Flow Cytometry to Detect Peripheral Blood and Bone Marrow Leukaemia Stem Cells for Relapse Prediction in P-AML
ClinicalTrials.gov study NCT06452732. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDS
ClinicalTrials.gov study NCT00053287. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of VAH as a Bridging Regimen to Allo-HCT in Relapsed/Refractory AML
ClinicalTrials.gov study NCT07091006. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Oral Venetoclax Tablets to Evaluate Adverse Events and Change in Disease Activity in Participants Above 19 Years of Age With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT04826523. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Respiratory Viral Infections During Acute Myeloid Leukemia (AML)Chemotherapy Related Aplasia
ClinicalTrials.gov study NCT01819792. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of A Venetoclax-based, Anthracycline-free Regimen in Newly Diagnosed CBFβ::MYH11(+) AML
ClinicalTrials.gov study NCT06429098. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.